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Objective: Cardiac surgery for congenital heart defects is commonly complicated by
shunt-induced chronic pulmonary hypertension and associated acute hypertensive
crises. To investigate the effects of vasodilators in chronic and acute pulmonary
hypertension, we used the innominate artery to create a growing aortopulmonary
shunt in young piglets.
Methods: Pulmonary hemodynamics and right ventricular function and their re-
sponses to hypoxia, intravenous prostacyclin, and inhaled nitric oxide were inves-
tigated after closure of the shunt by using pulmonary flow-pressure relationships,
pulmonary vascular resistance partitioning, pulmonary vascular impedance, and
ventriculoarterial coupling expressed as the ratio of right ventricular end-systolic
elastance to effective pulmonary arterial elastance.
Results: Shunt-induced pulmonary hypertension was associated with medial hyper-
trophy of pulmonary arteries, increased resistance, increased elastance, increased
wave reflection, and preserved ventriculoarterial coupling. Hypoxic pulmonary
vasoconstriction was blunted in the shunt group. Compared with prostacyclin,
inhaled nitric oxide was a more effective vasodilator in the shunt group and in
hypoxia. Effective pulmonary arterial elastance and right ventricular end-systolic
elastance increased in chronic (shunt) and acute (hypoxic) hypertension and de-
creased with vasodilators, preserving a normal coupling.
Conclusions: A growing aortopulmonary shunt in the young pig is a reliable model
of chronic pulmonary hypertension, with medial hypertrophy, increased resistance,
and increased elastance. In this model inhaled nitric oxide is a better pulmonary
vasodilator than intravenous prostacyclin, with neither drug having a specific
inotropic effect, and normal coupling is preserved in chronic and acute pulmonary
hypertension.
In congenital heart defects associated with left-to-right shunting, pulmonaryhypertension is an important determinant of morbidity and mortality aftersurgical shunt correction.1 In earlier stages of the disease, pulmonaryhypertension progressively resolves after the surgical correction. Vascularreactivity, however, remains increased for some days after the operationand can result in life-threatening postoperative hypertensive crises with
hypoxemia and right ventricular (RV) failure.1 Later in the evolution of the disease,
irreversible structural changes are present, and pulmonary hypertension might
persist despite surgical correction of the shunt.
Experimental attempts to reproduce the pulmonary hypertension associated with
left-to-right shunting have met with variable success. Better results have been
obtained after increased pressure and flow than after increased flow only2 in pigs
than in other species and in newborn than in young or adult animals.3 Authors who
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created an 8-mm aortopulmonary shunt in young pigs re-
ported medial hypertrophy and moderate pulmonary hyper-
tension after 3 months.3,4 Attempts to generate more hyper-
tension with a 10-mm shunt failed because of acute
pulmonary edema and death in all animals.4 We therefore
tried to obtain more pulmonary hypertension by using a
shunt that would grow with the animals.
Pulmonary hypertensive crises might be triggered by
hypoxemia, hypercapnia, metabolic acidosis, restlessness,
and endotracheal suctioning.1 The treatment consists of
oxygenation, hyperventilation, sedation, and muscle paral-
ysis. If pulmonary hypertension persists, administration of a
vasodilator is recommended. Prostacyclin and inhaled nitric
oxide (iNO) are potent drugs selected for vasodilator testing
in patients with pulmonary hypertension.5-7 Prostacyclin
and its analogues have been associated with an increase in
cardiac output and a positive inotropic effect,8,9 but they
cause systemic hypotension and inhibit platelet aggregation.
iNO might be a better pulmonary vasodilator after opera-
tions for congenital heart defects,10-12 but it has been asso-
ciated with an increase in left atrial pressure and a negative
inotropic effect.13,14
The aims of the present study were to investigate more
completely the changes in pulmonary vessels and the right
ventricle that occur in chronic high-pressure high-flow pul-
monary hypertension caused by an aortopulmonary shunt
and to compare the vasodilating effects of prostacyclin and
iNO in acute and chronic shunt-induced pulmonary hyper-
tension.
Methods
All experiments were conducted in accordance with the “Guide for
the Care and Use of Laboratory Animals” and after approval by the
Committee on the Care and Use of Animals in Research of the
Brussels Free University School of Medicine. Growing pigs were
enrolled immediately after weaning from maternal feeding (age
3-4 weeks).
Surgical Procedure
Animals were premedicated with 20 mg/kg intramuscular ket-
amine and 0.1 mg/kg intramuscular midazolam. After 0.25 mg of
intramuscular atropine, anesthesia was induced with 1 mg/kg in-
travenous midazolam and 10 g/kg intravenous fentanyl and
maintained with 0.1 mg · kg1 · h1 midazolam and 2 to 3 g ·
kg1 · h1fentanyl. Paralysis was obtained with 0.2 mg · kg1 ·
h1 intravenous pancuronium bromide. The pigs were ventilated
with an inspired oxygen fraction (FiO2) of 0.4, a tidal volume of 15
mL/kg, and a respiratory rate of 12 breaths/min. One gram of
intravenous cefazolin was given before and 2 hours after the
surgical procedure. A thoracotomy was performed through the
third intercostal space, and the left innominate artery (diameter,
5-6 mm) was dissected and anastomosed to the pulmonary artery
(Figure 1). At the end of the procedure, the shunt was either
maintained (shunt group, n  9) or closed (sham group, n  8).
The lungs were re-expanded, and pleural air was evacuated before
closure of the chest. The piglets were awakened and weaned from
mechanical ventilation. They received 5 mg of subcutaneous mor-
phine twice daily for 2 days and 20 mg of intramuscular furo-
semide to prevent pulmonary edema.
Preparation
Measurements were done 10 to 12 weeks later (77 3 days; range,
69-83 days), with the same anesthetic regimen as for the first
procedure. Anesthesia and mechanical ventilation were maintained
until the end of measurement. Femoral and pulmonary arterial
catheters were inserted to monitor pressures, to measure cardiac
output by means of thermodilution, and to draw arterial and mixed
venous blood. Thoracotomy was performed through the fourth left
intercostal space. A micromanometer-tipped catheter (SPC 350;
Millar Instrument, Houston, Tex) was introduced in the right
ventricle, and a pressure and velocity sensor catheter (SVPC-
664A, Millar) was introduced in the proximal main pulmonary
artery. Micromanometer-derived pressures were processed by us-
ing TCB-500 units (Millar), and velocity was processed by using
a FM501 flowmeter (Carolina Medical, King, NC). A tourniquet
was placed around the inferior vena cava to control cardiac output
by reducing venous return. The lungs were fully expanded, pleural
air was evacuated, and the chest was tightly closed.
Measurements
In each set of measurements, cardiac output was measured and
velocity and pressure signals were recorded in stable conditions for
calculation of pulmonary vascular impedance (PVZ) and RV func-
tion after inflation of the pulmonary arterial balloon for calculation
of capillary pressure and longitudinal pulmonary vascular resis-
tance partitioning and during vena caval compression for genera-
tion of flow-pressure curves. A complete set of measurements was
done at baseline in hyperoxia (FiO2 of 0.40) and repeated after 10
minutes of ventilation in hypoxia (FiO2 of 0.12). After return to
hyperoxia and 30 minutes of hemodynamic stabilization, prosta-
Figure 1. Illustration of the surgical procedure. The left innomi-
nate artery is connected to the main pulmonary artery to generate
a shunt that will increase over time to induce high-flow, high-
pressure pulmonary hypertension.
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cyclin (epoprostenol, Flolan; Glaxo-Smith-Kline, Genval, Bel-
gium) was started and incremented as 2 ng · kg1 · min1 every
10 minutes until side effects appeared (decrease in arterial pressure
of 30%, increase in heart rate of 30%, or premature beats).
Prostacyclin was decreased to the previous dose, and measure-
ments were made again in hyperoxia and in hypoxia. After dis-
continuation of prostacyclin, return to hyperoxia, and 30 minutes
of hemodynamic stabilization, iNO was administered at 40 ppm,
and measurements were done again in hyperoxia and in hypoxia
(iNO was not titrated because the 40-ppm dose yields a maximal
vasodilating response without causing side effects).
Data Analysis
All pressures and the velocity signals were digitized at 200 Hz and
stored on a PC for offline analysis. Velocity was converted to flow
by using the thermodilution value and was zeroed at the diastolic
zero-flow value. Flow-pressure plots were obtained from 5 beats
sampled throughout the flow-reduction maneuver.15 Pressures and
flow values were submitted to linear correlation analysis (r 0.95)
to generate individual regression lines and interpolate pulmonary
arterial pressure minus left atrial pressure (Ppa  Pla) values at
flows of 1.5 and 3.5 L · min1 · m2.15 Capillary pressure (Ppc)
was computed by means of biexponential fitting of the Ppa decay
curve after inflation of the balloon of the pulmonary artery cath-
eter.16 The arterial component of resistance was calculated as (Ppa
 Ppc)/(Ppa  Pla) and expressed as a percentage. PVZ was
calculated from the Fourier series expressions of pressure and flow
waves.17 From PVZ spectra were derived the 0-Hz impedance
modulus or total resistance (Zo), and the characteristic impedance
(Zc) was computed as the average of moduli between 2 and 15
Hz.17 The pressure wave was separated into forward and backward
components, and wave reflection was quantified as the amplitude
of the reflected wave (Rampl).18 Right ventriculoarterial coupling
was computed from RV pressure-volume curves by using a single-
beat method.19 The RV contractility was estimated as the slope of
the end-systolic pressure-volume relationship (Ees), and the pul-
monary effective arterial elastance (Ea) was estimated as the slope
of the end-diastolic to end-systolic relationship.20 Ventriculoarte-
rial coupling efficiency was defined as the Ees/Ea ratio.21
Pathology
Histologic examination was done by using standard methods.22 For
each animal, at least 10 blocks of formalin-fixed lung tissue, randomly
taken from the central and peripheral areas of the lungs, were paraffin
embedded by using standard protocols. Light microscopy was per-
formed without knowledge of the group allocation or hemodynamic
data. A hematoxylin-eosin stain and a resorcin-fuchsin stain for elastin
were performed on 5-m thick sections from each block. In each
piece 10 small muscular pulmonary arteries of variable diameter
(80-200 m) were studied. The medial thickness was measured with
an eyepiece micrometer as the distance between the internal and
external elastic laminae. Thickness was expressed as a percentage of
the external vessel diameter.
Statistical Analysis
Results are expressed as means  SE. Effects of shunt, hypoxia,
and vasodilators were assessed by means of repeated-measures
analysis of variance and Fisher protected t tests.
Results
After the operation, all piglets in the shunt group maintained
a loud continuous murmur in the left chest that increased
during the first week. Two piglets in the shunt group had
pulmonary edema after the operation and received addi-
tional furosemide; one died, and the other survived. One
piglet in the sham group had mediastinitis and died. At the
time of measurement, animals in the sham and shunt groups
had similar body weights (mean, 21 vs 20 kg). All pigs in
the shunt group had a patent shunt that had grown to the size
of 9 to 10 mm. The pulmonary/systemic flow ratio deter-
mined by means of oximetry was 1.75  0.07 (range,
1.36-2.00). After initial measurements, the shunt was closed
to correctly evaluate pulmonary vascular resistance and
PVZ.
Effects of Shunts
Before closure of the shunt and after the initial fluid admin-
istration reached a left atrial pressure of about 8 mm Hg,
animals in the shunt group had a similar flow but higher Ppa
than animals in the sham group (40 1 vs 26 1 mm Hg).
Other hemodynamic variables were comparable in the 2
groups (Table 1). Closure of the shunt reduced pulmonary
blood flow (3.3-2.4 L · min1 · m2) and Ppa in the shunt
group but did not affect the distribution of arterial and
venous resistances (Table 1). Flow-pressure plots were
shifted to higher pressures in the shunt group (Figure 2). All
the following data were collected at a similar flow of 2 to
TABLE 1. Baseline hemodynamics and blood gases in pig-
lets in the sham and shunt groups
Sham Shunt
Baseline
Before
closure Baseline
Q, L  min1  m2 3.6 0.2 3.3 0.3 2.4 0.2*
HR, beats/min 115 8 109 9 126 14
Psa, mm Hg 118 10 127 6 121 6
Pra, mm Hg 6 1 6 1 7 1
Ppa, mm Hg 26 1 40 1* 27 1*
Ppc, mm Hg 13 1 – 16 1
Pla, mm Hg 7 1 8 1 8 1
PVRa, % 65 3 – 68 3
pHa 7.49 0.01 7.45 0.02 7.42 0.03
PaCO2, mm Hg 39 2 35 1 37 2
PVO2, mm Hg 201 23 173 15 176 15
PaO2, mm Hg 46 1 42 4 43 4
Values are means  SE. Q, Flow; HR, heart rate; Psa, systemic arterial
pressure; Pra, right atrial pressure; Ppa, pulmonary arterial pressure; Ppc,
pulmonary capillary pressure; Pla, left atrial pressure; PVRa, arterial com-
ponent of pulmonary vascular resistance; PvO2, partial pressure of oxygen,
mixed venous.
*P  .05 versus previous column.
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2.5 L · min1 · m2 by decreasing venous return to allow for
meaningful comparisons (Tables 2-4). Compared with that
in the sham group, the pulmonary circulation in animals in
the shunt group was characterized by increases in Zo, Zc,
and Rampl. The right ventricle showed a marked increase in
afterload and in contractility (Ea and Ees). Pathologic ex-
amination showed a medial thickness of 11%  1% in the
shunt group versus 7%  1% in the sham group (P  .05).
Some animals in the shunt group showed nonspecific indi-
ces of congestion (interstitial and alveolar edema, widened
lymphatic vessels, and venous wall thickening). No differ-
ence was found between smaller and larger arteries in the
investigated range (80-200 m).
Effects of Hypoxia
In the sham group hypoxia markedly shifted the pressure-
flow plots upward (Figure 2). Ppa and Ppc increased pro-
portionally, indicating changes in both arterial and venous
resistances. PVZ data showed a hypoxia-induced increase in
Zo, Zc, and Rampl (Table 2). Ventricular data showed a
hypoxia-induced increase in Ea and a proportional increase
in Ees, resulting in a preservation of Ees/Ea. In the shunt
group flow-pressure plots, PVZ data, and RV data remained
unaffected by hypoxia.
Effect of Prostacyclin and iNO
Two piglets in the shunt group died from ventricular tachy-
cardia and fibrillation when prostacyclin was increased from
2 to 4 ng · kg1 · min1. Other side effects in the shunt and
sham groups were premature beats in 10 pigs, hypotension
in 2 pigs, and low cardiac output in 1 pig at 18 ng · kg1 ·
min1. At the time of measurement, the prostacyclin infu-
sion rate was 11  2 ng · kg1 · min1 (range, 4-20 ng ·
kg1 · min1) in the sham group and 11  2 ng · kg1 ·
min1 (range, 4-18 ng · kg1 · min1) in the shunt group;
for comparison, our patients with pulmonary hypertension
tested for reversibility received 4 to 16 ng · kg1 · min1. At
baseline, prostacyclin had no effect on flow-pressure plots
(Figure 3), on PVZ, or on ventriculoarterial coupling (Table
3). iNO shifted flow-pressure plots downward in both the
sham and shunt groups (Figure 3). iNO reduced Zo, Zc, and
Ees in the shunt group but not in the sham group (Table 3).
Compared with prostacyclin, iNO reduced Zo, Zc, and Ees
in the shunt group (Table 3). During hypoxia, prostacyclin
somewhat shifted flow-pressure plots downward in the
sham and shunt groups, whereas iNO had a more marked
effect (Figure 4). At reference flow, iNO decreased Zo and
Zc more than prostacyclin (Table 4). iNO decreased Ees
compared with prostacyclin, but Ees/Ea was unaffected by
both drugs.
Discussion
Experimental Model
Previous attempts to generate pulmonary hypertension with
an aortopulmonary shunt had variable success. In utero
aortopulmonary fistulas are associated with technical prob-
lems and high mortality.23,24 In young piglets Rendas and
associates3 reported more pulmonary hypertension in
4-week-old animals than in older animals. Pulmonary hy-
pertension, however, remained moderate with 8-mm fistu-
las, whereas severe pulmonary edema occurred with 10-mm
fistulas.4 The present study shows that serious chronic pul-
monary hypertension can be reliably caused by an aortopul-
Figure 2. Composite pulmonary vascular flow pressure curves in the sham and shunt groups (means  SE). Effects
of hypoxia: *P < .01 versus baseline, £P < .05 versus sham. Pigs in the shunt group showed an upward shift of
flow-pressure curves. Hypoxia shifted these curves upward in the sham group but not in the shunt group.
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monary shunt created with the left innominate artery in
growing piglets. The surgical procedure is simple, and se-
rious complications are uncommon because of the limited
initial size of the fistula. The size of the fistula almost
doubled over the 10 to 12 weeks, reaching a 9- to 10-mm
diameter that would be lethal at the time of the operation. In
comparison with an 8-mm fistula, the final 20% increase in
diameter represented a 44% increase in section area and a
theoretic 77% decrease in resistance. This larger final shunt
explains why pulmonary hypertension was more severe in
our study than in previous studies. In turn, the pulmonary
hypertension explains why the pulmonary/systemic flow
ratio was limited to about 1.75 at the time of measurement.
Pathology
Histologic examination essentially showed medial hypertro-
phy of the 80- to 200-m muscular pulmonary arteries in
the shunt group. Part of this observation could be due to
arterial relaxation in the absence of distending pressure
during fixation. However, the difference between groups is
so large (50%) that it is unlikely to result only from
arterial retraction. Moreover, this finding is consistent with
grade 1 changes reported in patients with pulmonary arterial
hypertension related to congenital left-to-right shunts.2,25,26
Further stages of this type of pulmonary hypertensive vas-
cular disease include concentric laminar intimal fibrosis,
fibrinoid necrosis, dilatations, and plexiform lesions, espe-
cially in the proximal parts of the supernumerary arteries.25
Such features of advanced pulmonary hypertension were
not found in our animals.
Pulmonary Hemodynamics
Most previous investigations on aortopulmonary shunts re-
ported data collected when the shunt was patent or used
pressures obtained at variable flow, so that the extent of
pulmonary hypertension remained unclear.3,24,27 In studies
in which data were taken after closure of the shunt and at
controlled flow, pulmonary arterial pressure and resistance
increased by about 25%.4,28 In the present study the increas-
ing size and longer duration of the shunt resulted in an
approximately 50% increase in pulmonary arterial pressure
and resistance. A previous study using the double-occlusion
TABLE 2. PVZ and right ventriculoarterial coupling in piglets in the sham and shunt groups
Sham Shunt
Baseline Hypoxia Baseline Hypoxia
Q, L  min1  m2 2.2 0.1 2.3 0.2 2.4 0.1 2.4 0.1
Ppa, mm Hg 16 2 31 2* 27 1† 29 1
Zo, dynes  s1  cm5 600 68 1087 106* 918 76 966 96
Zc, dynes  s1  cm5 64 7 126 18* 130 16† 160 12
Rampl, mm Hg 3.5 0.5 5.3 0.6* 4.8 0.7 6.9 1.4*
Ea, mm Hg/mL 1.3 0.2 3.2 0.7* 2.2 0.2† 2.0 0.2
Ees, mm Hg/mL 1.8 0.4 4.7 0.8 4.9 0.8† 3.6 0.8
Ees/Ea 1.4 0.3 1.5 0.2 2.2 0.3 1.8 0.3
Values are means  SE. Ea, Effective pulmonary arterial elastance; Ees, RV end-systolic elastance; Ppa, pulmonary arterial pressure; Q, flow; Rampl,
reflected wave amplitude; Zc, characteristic impedance; Zo, total pulmonary vascular resistance.
*P  .05 versus baseline;
†P  .05 versus sham.
TABLE 3. PVZ and right ventriculoarterial coupling: Effect of prostacyclin and iNO
Sham Shunt
Baseline Prostacyclin iNO Baseline Prostacyclin iNO
Q, L  min1  m2 2.2 0.1 2.4 0.2 2.2 0.1 2.4 0.1 2.4 0.1 2.5 0.1
Ppa, mm Hg 16 2 20 2 14 2† 27 1 26 1 18 1*†
Zo, dynes  s1 cm5 600 68 688 38 479 56† 918 76 851 77 577 43*†
Zc, dynes  s1 cm5 64 7 76 11 77 6 130 16 165 54 91 9*†
Rampl, mm Hg 3.5 0.5 3.3 0.6 3.7 0.8 4.8 0.7 5.1 0.8 3.4 0.7*†
Ea, mm Hg/mL 1.3 0.2 1.7 0.3 1.4 0.3 2.2 0.2 1.7 0.2 1.8 0.4
Ees, mm Hg/mL 1.8 0.4 2.8 0.7 2.4 0.3 4.9 0.8 3.9 0.5 2.8 0.4*
Ees/Ea 1.4 0.3 1.7 0.4 1.8 0.3 2.2 0.3 2.3 0.4 1.6 0.4
Values are means  SE. Ea, Effective pulmonary arterial elastance; Ees, RV end-systolic elastance; Ppa, pulmonary arterial pressure; Q, flow; Rampl,
reflected wave amplitude; Zc, characteristic impedance; Zo, total pulmonary vascular resistance.
*P  .05 versus baseline,
†P  .05 versus prostacyclin.
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method reported that a 14-month subclavian-pulmonary
shunt increased arterial but not venous resistance in the
shunted left lower lobe vasculature.27 We used a single
occlusion method with a 3-compartment model and biex-
ponential fitting that has been shown to yield values closest
to those of the double-occlusion method.16 In the present
study involving the complete pulmonary vasculature, our
results show proportional increases in arterial and venous
resistances, suggesting that pulmonary veins also contrib-
uted to the increased resistance. Impedance data showed
normal values in the sham group29 and significant changes
in the shunt group. Zo and Zc increased markedly, which is
in keeping with previous observations in shunted animals4
and in children with grade I pulmonary vascular disease
caused by a congenital left-to-right shunt.26 The increase in
Zo reflects the upward shift of flow-pressure curves. The
increase in Zc might be related to a decreased cross-sec-
tional area or an increased elastance (increased stiffness and
decreased compliance) of the proximal arteries. Because the
proximal arteries are passively dilated in pulmonary hyper-
tension, increased Zc thus indicates increased arterial elas-
tance. Our results also show increased reflected wave am-
plitude, an usual consequence of increased elastance and
wave velocity. Shunt-induced pulmonary hypertension was
thus associated with a consistent hemodynamic picture of
increased resistance of small distal vessels, increased elas-
TABLE 4. PVZ and right ventriculoarterial coupling: Effect of prostacyclin and iNO during hypoxia
Sham-hypoxia Shunt-hypoxia
Baseline Prostacyclin iNO Baseline Prostacyclin iNO
Q, L  min1  m1 2.3 0.2 2.3 0.1 2.3 0.1 2.4 1 2.4 1 2.6 2*†
Ppa, mm Hg 31 2 25 3* 21 3*† 29 1 30 3 21 1*†
Zo, dynes  s1  cm5 1087 106 867 94* 671 77*† 966 96 1053 92 645 52*†
Zc, dynes  s1  cm5 126 18 99 11* 71 9*† 160 12 138 17 93 9*†
Rampl, mm Hg 5.3 0.6 4.5 0.9 4.2 0.6 6.9 1.4 5.0 1.0 3.0 0.6*†
Ea, mm Hg/mL 3.2 0.7 2.9 0.7 1.9 0.3*† 2.0 0.1 2.8 0.3* 1.7 0.2*†
Ees, mm Hg/mL 4.7 1.0 4.9 1.4 3.7 0.8 3.6 0.8 5.0 1.4* 3.8 0.6
Ees/Ea 1.5 0.2 1.7 0.5 1.9 0.4 1.8 0.3 1.8 0.4 2.2 0.5
Values are means  SE. Ea, Effective pulmonary arterial elastance; Ees, RV end-systolic elastance; Ppa, pulmonary arterial pressure; Q, flow; Rampl,
reflected wave amplitude; Zc, characteristic impedance; Zo, total pulmonary vascular resistance.
*P  .05 versus baseline,
†P  .05 versus prostacyclin.
Figure 3. Effect of intravenous prostacyclin (PGI2) and iNO on pulmonary vascular flow-pressure curves in pigs in
the sham and shunt groups (means  SE). *P < .05 versus baseline (BL), §P < .05 iNO versus prostacyclin. iNO
shifted the curves downward in sham-treated pigs.
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tance of large proximal vessels, and increased amplitude of
wave reflection, all of which contribute to the increase in
RV afterload.
RV Function
Ees and Ea, commonly used to assess ventriculoarterial
coupling for the left ventricle, can also be used for the
normal right ventricle19 and for the right ventricle facing
pulmonary hypertension (Wauthy and colleagues, unpub-
lished observations). Ea integrates the major components of
ventricular afterload (distal resistance, proximal elastance,
and wave reflection), Ees reflects ventricular contractility,
and the Ees/Ea ratio directly quantifies the ventriculoarterial
coupling efficiency. Pigs in the sham group had a higher Ea
than normal dogs, reflecting the natural increase in resis-
tance and elastance of the pulmonary circulation of this
species.29 Ees increased in such a way that the Ees/Ea ratio
remained close to 2, the value also found in dogs and taken
as optimal because it is associated with a maximal ratio
between mechanical work production and oxygen consump-
tion.21 Piglets in the shunt group had a further increase in
Ea, confirming that the shunt-induced increases in resis-
tance and elastance resulted in an increased RV afterload.
Ees again increased in such a way that Ees/Ea remained
close to the optimal value of 2. In other words, the right
ventricle did adapt to match the chronically increased after-
load related both to the species’ features and to the chronic
aortopulmonary shunt.
Hypoxia
In the sham group acute hypoxia was associated with an
increase in pulmonary vascular resistance and elastance.
Such effects have been reported previously and might be
attributed to hypoxia itself and to the resulting adrenergic
stimulation.15,29 In the shunt group the hypoxic response
was significantly blunted. Previous studies reported aorto-
pulmonary shunts both to enhance24 and to blunt4,30 hy-
poxic responses.
Vasodilators
Prostacyclin and NO are natural vasodilators produced by
endothelial cells and acting on smooth muscle cells to
maintain a low basal pulmonary vascular tone.10 Both sub-
stances have been used as potent vasodilating drugs in
various states associated with pulmonary hypertension.8-11
Here, at baseline, prostacyclin had no significant effect, and
iNO had only a mild vasodilating effect. These results
indicate that basal pulmonary vascular tone was low be-
cause of the anesthesia, the normal blood flow and blood
pressure, or both. In chronic (shunt-induced) pulmonary
hypertension, prostacyclin had no effect, whereas iNO de-
creased resistance and elastance. In acute (hypoxic) pulmo-
nary hypertension, whether isolated or superimposed on
chronic hypertension, prostacyclin partially reversed and
iNO almost completely reversed the increases in resistance
and elastance. Whether in acute or chronic pulmonary hy-
pertension, iNO was thus a better pulmonary vasodilator
than prostacyclin. Ea reflected the effects of resistance,
Figure 4. Effect of intravenous prostacyclin (PGI2) and iNO during hypoxia on pulmonary vascular flow-pressure
curves in pigs in the sham and shunt groups (means  SE). *P < .05 versus baseline (BL), §P < .05 versus
prostacyclin. iNO shifted the curves downward more than prostacyclin.
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elastance, and wave reflections on RV afterload. Ees again
increased or decreased in such a way that the ventriculoar-
terial coupling efficiency was maintained. This absence of
change in Ees/Ea suggests that neither prostacyclin nor iNO
had a specific RV inotropic effect in the present experi-
ments.
Conclusions
We used the left innominate artery to create an aortopul-
monary shunt in growing pigs that increased from 5 to 6 to
9 to 10 mm diameter over a period of 10 to 12 weeks.
Pulmonary vascular changes were characterized by medial
hypertrophy of small arteries and a corresponding increase
in resistance, elastance, and wave reflection. RV contractil-
ity increased to match the increased afterload, thus preserv-
ing ventriculoarterial coupling efficiency. iNO reversed
both chronic (shunt-induced) and acute (hypoxic) pulmo-
nary hypertension better than prostacyclin. Neither drug had
a specific inotropic effect.
C. Me´lot, MD, PhD, MScBiostat, reviewed the statistical meth-
ods.
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